1 of 1
Story summary
- U.S. President Donald Trump launched a Medicaid drug-price pilot with Pfizer and 25 firms.
- The Generous model pilot requires each state to opt-in and meet conditions.
- States had to apply by Sept. 10, with Massachusetts opting in and California seeking details.
- Medicaid covers 66 million Americans, with drug spending rising 46% from 2019 to 2024, reaching $46 billion.
- Analysts warn states could face higher Medicaid costs if pricing expands access to expensive drugs.
